APA (7th ed.) Citation

Cvetanović, A. S., Jankovic, K. B., Stojković, A. S., Živković, N. D., Kostić, M. S., & Popović, L. S. (2026). Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer. Cancers, 18(2), 242. https://doi.org/10.3390/cancers18020242

Chicago Style (17th ed.) Citation

Cvetanović, Ana S., Kristina B. Jankovic, Ana S. Stojković, Nikola D. Živković, Miloš S. Kostić, and Lazar S. Popović. "Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer." Cancers 18, no. 2 (2026): 242. https://doi.org/10.3390/cancers18020242.

MLA (9th ed.) Citation

Cvetanović, Ana S., et al. "Real-World Clinical Experience of First-Line Ribociclib Combined with an Aromatase Inhibitor in Metastatic Breast Cancer." Cancers, vol. 18, no. 2, 2026, p. 242, https://doi.org/10.3390/cancers18020242.